血液系统肿瘤中的多药耐药蛋白1/ P-糖蛋白 - Suppr

Suppr

超能文献

MDR1/P-glycoprotein in haematological neoplasms.

作者信息

Marie J P, Zhou D C, Gurbuxani S, Legrand O, Zittoun R

机构信息

Department of Haematology, University Paris VI, France.

出版信息

Eur J Cancer. 1996 Jun;32A(6):1034-8. doi: 10.1016/0959-8049(96)00055-x.

DOI:10.1016/0959-8049(96)00055-x

PMID:8763345

Abstract

摘要

相似文献

MDR1/P-glycoprotein in haematological neoplasms.血液系统肿瘤中的多药耐药蛋白1/ P-糖蛋白

Eur J Cancer. 1996 Jun;32A(6):1034-8. doi: 10.1016/0959-8049(96)00055-x.

Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignancies.急性髓系白血病及其他血液系统恶性肿瘤中多药耐药的逆转

Eur J Cancer. 1996 Jun;32A(6):1062-9. doi: 10.1016/0959-8049(96)00054-8.

Is p-glycoprotein a potential target for reversing clinical drug resistance?

Curr Opin Oncol. 1994 Nov;6(6):595-600. doi: 10.1097/00001622-199411000-00011.

Pharmacological considerations in the modulation of multidrug resistance.多药耐药性调控中的药理学考量

Eur J Cancer. 1996 Jun;32A(6):1082-8. doi: 10.1016/0959-8049(96)00111-6.

Reversal of multidrug resistance in hematological malignancies.

Blood Rev. 1999 Jun;13(2):67-78. doi: 10.1016/s0268-960x(99)90013-9.

Diagnosis and reversal of multidrug resistance in paediatric cancers.儿童癌症中多药耐药的诊断与逆转

Eur J Cancer. 1996 Jun;32A(6):1051-61. doi: 10.1016/0959-8049(96)00085-8.

P-glycoprotein--a mediator of multidrug resistance in tumour cells.P-糖蛋白——肿瘤细胞多药耐药的一种介质。

Eur J Cancer. 1996 Jun;32A(6):927-44. doi: 10.1016/0959-8049(96)00057-3.

Biology of the multidrug resistance-associated protein, MRP.多药耐药相关蛋白MRP的生物学特性

Eur J Cancer. 1996 Jun;32A(6):945-57. doi: 10.1016/0959-8049(96)00046-9.

Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?多药耐药性（P-糖蛋白）是意义未明的单克隆丙种球蛋白病、浆细胞瘤、多发性骨髓瘤和淀粉样变性患者浆细胞的固有特征吗？

Leuk Lymphoma. 1998 May;29(5-6):577-84. doi: 10.3109/10428199809050917.

Specificity and sensitivity of immunocytochemistry for detecting P-glycoprotein in haematological malignancies.免疫细胞化学检测血液系统恶性肿瘤中P-糖蛋白的特异性和敏感性

J Clin Pathol. 1994 Jul;47(7):619-24. doi: 10.1136/jcp.47.7.619.

引用本文的文献

A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells.一种使用百部叶碱的药理学策略，用于对人类多药耐药白血病细胞进行更有效的化疗治疗。

Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3533-3543. doi: 10.31557/APJCP.2018.19.12.3533.

Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells .甲磺酸伊马替尼对比依托泊苷治疗敏感及耐药慢性髓性白血病细胞的疗效

Exp Ther Med. 2017 Jun;13(6):3209-3216. doi: 10.3892/etm.2017.4443. Epub 2017 May 8.

Norcantharidin, derivative of cantharidin, for cancer stem cells.去甲斑蝥素，斑蝥素的衍生物，用于癌症干细胞。

Evid Based Complement Alternat Med. 2013;2013:838651. doi: 10.1155/2013/838651. Epub 2013 Sep 2.

Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid).基于聚（β-L-苹果酸）的多功能纳米载体通过pH控制的腙键实现阿霉素的细胞递送。

Int J Mol Sci. 2012;13(9):11681-11693. doi: 10.3390/ijms130911681. Epub 2012 Sep 17.

Expression of MRP1 gene in acute leukemia.MRP1基因在急性白血病中的表达。

Sao Paulo Med J. 2008 May 1;126(3):172-9. doi: 10.1590/s1516-31802008000300007.

Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).口服抑制剂CBT-1((R))对P-糖蛋白（ABCB1）和多药耐药相关蛋白1（ABCC1）介导的转运的抑制作用

Biochem Pharmacol. 2008 Mar 15;75(6):1302-12. doi: 10.1016/j.bcp.2007.12.001. Epub 2007 Dec 14.

The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.阿霉素的生物还原激活在对白血病HL60敏感细胞系及其多药耐药亚系的细胞毒性活性中的作用。

Br J Cancer. 2005 Jul 11;93(1):89-97. doi: 10.1038/sj.bjc.6602639.

Influence of RARalpha gene on MDR1 expression and P-glycoprotein function in human leukemic cells.维甲酸受体α（RARα）基因对人白血病细胞中多药耐药基因1（MDR1）表达及P-糖蛋白功能的影响

Cancer Cell Int. 2005 May 24;5:15. doi: 10.1186/1475-2867-5-15.

In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia.在诱导化疗前体内使用全反式维甲酸可提高初发急性髓性白血病患者的完全缓解率，并增加罗丹明123摄取量。

Med Oncol. 2002;19(1):59-67. doi: 10.1385/MO:19:1:59.

Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells.强力霉素诱导MCF - 7乳腺癌细胞中P糖蛋白的表达。

Antimicrob Agents Chemother. 2002 Mar;46(3):755-61. doi: 10.1128/AAC.46.3.755-761.2002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验